Brief: Sana Biotechnology Reports Q4 And Full Year 2021 Financial Results
16/03/2022 12:34
March 16 (Reuters) - Sana Biotechnology Inc SANA.O :
* SANA BIOTECHNOLOGY REPORTS FOURTH QUARTER AND FULL YEAR
2021
FINANCIAL RESULTS AND BUSINESS UPDATES
* SANA BIOTECHNOLOGY INC - QTRLY LOSS PER SHARE $0.60
Source text for Eikon: ID:nGNXbn1jzX
Further company coverage: SANA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sana Biotechnology
See all newsSana Biotechnology Inc reports results for the quarter ended June 30 - Earnings Summary
Sana Biotechnology Q2 adjusted loss narrows, beats estimates
Brief: Sana Biotechnology Q2 Adjusted EPS USD -0.13 Vs. IBES Estimate USD -0.15
Sana Biotechnology posts Q1 adjusted loss narrower than expected, extends cash runway
Brief: Sana Biotechnology Q1 Adjusted EPS USD -0.14 Vs. IBES Estimate USD -0.17